Congenital Adrenal Hyperplasia (CAH)

fluo

The NEONATAL 17-OHP Screening FLISA is a fluorescent enzyme immunoassay designed for the quantitative measurement of 17 alpha-hydroxyprogesterone (17-OHP). This device is specifically intended for neonatal samples, utilizing blood spots dried on 903® or 226 filter paper.
This assay is dedicated to professional use in diagnostic laboratories. The device is not for self-testing.

The NEONATAL17-OHP Screening FLISA is a competitive ELISA in which both 17-OHP contained in the blood specimen and a labelled-17-OHP competitively bind to the anti-17-OHP antibodies covering the microplate. The labelled-17OHP is measured through the oxidation of 3-(4-Hydroxyphenyl)propionic acid (HPPA) by Horseradish Peroxidase (HRP)-labelled detection antibody, producing a fluorescent product. The measured fluorescent signal is therefore inversely proportional to the concentration of 17-OHP present in the newborn dried blood spot.

General information

Format: 192 – 576 determinations
Storage: At 2-8°C
Possible automation: Yes
Turn around time: Less than 3 hours

Test principle

Congenital adrenal hyperplasia (CAH) refers to a group of disorders resulting from defective steroidogenesis. There are several types of congenital adrenal hyperplasia described: deficiency of 21-Hydroxylase, 17-α-Hydroxylase, 3-β-Hydroxysteroid Dehydrogenase, 11-β-Hydroxylase, or Cytochrome P450 Oxidoreductase and finally congenital lipoid adrenal hyperplasia.

In more than 90-95% of cases, CAH is caused by a deficiency in enzyme 21-Hydroxylase, which controls the production of cortisol and aldosterone in the adrenal gland. This 21-Hydroxylase deficiency is subdivided into two subcategories:

Classic congenital adrenal hyperplasia, which itself can be categorized as salt loss and simple virilizing forms. Classic CAH is the most serious form and can lead to adrenal crisis and premature death if not managed quickly.

The most common symptoms of classical CAH are hypertrophic adrenal glands producing excessive quantities of androgens, with aldosterone deficiency. The result is excessive salt loss from birth, leading to hyponatremia, dehydration, hypovolemia and hypotension, which endangers the patient’s survival. In girls, sexual ambiguity with varying degrees of virilization is usually present.

In infants, the determination of 17-hydroxyprogesterone (17-OHP) levels can identify classic forms of 21-Hydroxylase deficiency. Because premature babies typically have higher 17-OHP concentrations, the cut-off is often weighted by gestational age at birth and/or newborn weight.